Protective effect of luteolin on the transgenic Drosophila model of Parkinson’s disease

Detalhes bibliográficos
Autor(a) principal: Siddique, Yasir Hasan
Data de Publicação: 2018
Outros Autores: Jyoti, Smita, Naz, Falaq
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/153877
Resumo: In the present study we have studied the effect of 25, 50, 75 and 100 µM of luteolin on the transgenic Drosophila expressing human alpha synuclein. The doses of luteolin were established in diet and the PD flies were allowed to feed on it for 24 days. After 24 days of exposure the flies were assayed for climbing assay, oxidative stress markers, caspase-3 & 9 activity and dopamine content. The immunohistochemistry was also performed on the brain sections for the activity of tyrosine hydroxylase. The exposure of luteolin showed a dose dependent delay in the loss of climbing ability and activity, reduction in oxidative stress markers, caspase-3&9 activities and results in an increase in the dopamine content. The results obtained for the immunohistochemistry also supports the protective role of luteolin against the damage of the dopaminergic neurons.
id USP-31_8383eb38489cef4d94fe8fd8cddcf678
oai_identifier_str oai:revistas.usp.br:article/153877
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Protective effect of luteolin on the transgenic Drosophila model of Parkinson’s diseaseLuteolinParkinson’s diseaseDrosophilaOxidative stressIn the present study we have studied the effect of 25, 50, 75 and 100 µM of luteolin on the transgenic Drosophila expressing human alpha synuclein. The doses of luteolin were established in diet and the PD flies were allowed to feed on it for 24 days. After 24 days of exposure the flies were assayed for climbing assay, oxidative stress markers, caspase-3 & 9 activity and dopamine content. The immunohistochemistry was also performed on the brain sections for the activity of tyrosine hydroxylase. The exposure of luteolin showed a dose dependent delay in the loss of climbing ability and activity, reduction in oxidative stress markers, caspase-3&9 activities and results in an increase in the dopamine content. The results obtained for the immunohistochemistry also supports the protective role of luteolin against the damage of the dopaminergic neurons.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2018-11-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/15387710.1590/s2175-97902018000317760Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 3 (2018); e17760Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 3 (2018); e17760Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 3 (2018); e177602175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/153877/150224Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)info:eu-repo/semantics/openAccessSiddique, Yasir HasanJyoti, SmitaNaz, Falaq2019-03-17T13:19:41Zoai:revistas.usp.br:article/153877Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2019-03-17T13:19:41Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Protective effect of luteolin on the transgenic Drosophila model of Parkinson’s disease
title Protective effect of luteolin on the transgenic Drosophila model of Parkinson’s disease
spellingShingle Protective effect of luteolin on the transgenic Drosophila model of Parkinson’s disease
Siddique, Yasir Hasan
Luteolin
Parkinson’s disease
Drosophila
Oxidative stress
title_short Protective effect of luteolin on the transgenic Drosophila model of Parkinson’s disease
title_full Protective effect of luteolin on the transgenic Drosophila model of Parkinson’s disease
title_fullStr Protective effect of luteolin on the transgenic Drosophila model of Parkinson’s disease
title_full_unstemmed Protective effect of luteolin on the transgenic Drosophila model of Parkinson’s disease
title_sort Protective effect of luteolin on the transgenic Drosophila model of Parkinson’s disease
author Siddique, Yasir Hasan
author_facet Siddique, Yasir Hasan
Jyoti, Smita
Naz, Falaq
author_role author
author2 Jyoti, Smita
Naz, Falaq
author2_role author
author
dc.contributor.author.fl_str_mv Siddique, Yasir Hasan
Jyoti, Smita
Naz, Falaq
dc.subject.por.fl_str_mv Luteolin
Parkinson’s disease
Drosophila
Oxidative stress
topic Luteolin
Parkinson’s disease
Drosophila
Oxidative stress
description In the present study we have studied the effect of 25, 50, 75 and 100 µM of luteolin on the transgenic Drosophila expressing human alpha synuclein. The doses of luteolin were established in diet and the PD flies were allowed to feed on it for 24 days. After 24 days of exposure the flies were assayed for climbing assay, oxidative stress markers, caspase-3 & 9 activity and dopamine content. The immunohistochemistry was also performed on the brain sections for the activity of tyrosine hydroxylase. The exposure of luteolin showed a dose dependent delay in the loss of climbing ability and activity, reduction in oxidative stress markers, caspase-3&9 activities and results in an increase in the dopamine content. The results obtained for the immunohistochemistry also supports the protective role of luteolin against the damage of the dopaminergic neurons.
publishDate 2018
dc.date.none.fl_str_mv 2018-11-29
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/153877
10.1590/s2175-97902018000317760
url https://www.revistas.usp.br/bjps/article/view/153877
identifier_str_mv 10.1590/s2175-97902018000317760
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/153877/150224
dc.rights.driver.fl_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 3 (2018); e17760
Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 3 (2018); e17760
Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 3 (2018); e17760
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222913819836416